[HTML][HTML] Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis

Y Feng, M Spezia, S Huang, C Yuan, Z Zeng, L Zhang… - Genes & diseases, 2018 - Elsevier
As the most commonly occurring cancer in women worldwide, breast cancer poses a
formidable public health challenge on a global scale. Breast cancer consists of a group of …

Molecular classification of breast cancer

JYS Tsang, MT Gary - Advances in anatomic pathology, 2020 - journals.lww.com
Cancer classification aims to provide an accurate diagnosis of the disease and prediction of
tumor behavior to facilitate oncologic decision making. Traditional breast cancer …

Multi-omic machine learning predictor of breast cancer therapy response

SJ Sammut, M Crispin-Ortuzar, SF Chin, E Provenzano… - Nature, 2022 - nature.com
Breast cancers are complex ecosystems of malignant cells and the tumour
microenvironment. The composition of these tumour ecosystems and interactions within …

m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer

B Zhang, Q Wu, B Li, D Wang, L Wang, YL Zhou - Molecular cancer, 2020 - Springer
Background The epigenetic regulation of immune response has been demonstrated in
recent studies. Nonetheless, potential roles of RNA N6-methyladenosine (m 6 A) …

Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures

D Zeng, M Li, R Zhou, J Zhang, H Sun, M Shi… - Cancer immunology …, 2019 - AACR
Tumor microenvironment (TME) cells constitute a vital element of tumor tissue. Increasing
evidence has elucidated their clinicopathologic significance in predicting outcomes and …

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

D Hammerl, JWM Martens, M Timmermans… - Nature …, 2021 - nature.com
Only a subgroup of triple-negative breast cancer (TNBC) responds to immune checkpoint
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …

Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer

H Chen, J Yao, R Bao, Y Dong, T Zhang, Y Du… - Molecular cancer, 2021 - Springer
Background The four major RNA adenosine modifications, ie, m 6 A, m 1 A, alternative
polyadenylation, and adenosine-to-inosine RNA editing, are mediated mostly by the “writer” …

Tumor heterogeneity in breast cancer

G Turashvili, E Brogi - Frontiers in medicine, 2017 - frontiersin.org
Breast cancer is a heterogeneous disease and differs greatly among different patients
(intertumor heterogeneity) and even within each individual tumor (intratumor heterogeneity) …

[HTML][HTML] Improved breast cancer histological grading using deep learning

Y Wang, B Acs, S Robertson, B Liu, L Solorzano… - Annals of …, 2022 - Elsevier
Background The Nottingham histological grade (NHG) is a well-established prognostic
factor for breast cancer that is broadly used in clinical decision making. However,∼ 50% of …

[HTML][HTML] Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis

N Aceto, A Bardia, DT Miyamoto, MC Donaldson… - Cell, 2014 - cell.com
Circulating tumor cell clusters (CTC clusters) are present in the blood of patients with cancer
but their contribution to metastasis is not well defined. Using mouse models with tagged …